Hepatology Fellow Publications, Abstracts & Presentations
A list of recent Hepatology Fellowship Program publications, abstracts, and presentations is available below. Current and recent fellows are in bold.
Recent Publications
Hitawala, A and Ghany MG. Hepatitis D. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease Mark Feldman, Lawrence S. Friedman, Ray Chung and Lawrence J. Brandt. 12th, Edition. 2024. In Press.
Hitawala A.A., Gopalakrishna H., Mironova M., Livinski A.A., Wright E.C., Downing T., Ito S., Fisher S.D., Cedars A.M., John A.S., Heller T. Meta-Analysis: Incidence of Cirrhosis and Hepatocellular Carcinoma in Patients with Fontan Palliation. Alimentary Pharmacology and Therapeutics. In Press
Gopalakrishna H, Nair GB, Salman Roghani R, Ravendhran N, Rotman Y. Optimizing surveillance of low-risk metabolic dysfunction associated steatotic liver disease using transient elastography. Eur J Gastroenterol Hepatol. 2024 Apr 1;36(4):476-481. doi: 10.1097/MEG.0000000000002713. Epub 2024 Feb 16
Gopalakrishna H, Asif B, Rai A, Conjeevaram HS, Mironova M, Kleiner DE, Freeman AF, Heller T. Chronic Liver Disease in Patients with Prolidase Deficiency: A Case Series. Case Rep Gastroenterol. 2024 Feb 1;18(1):49-57. doi: 10.1159/000536117.
Gopalakrishna, H., Ghany, M.G. Perspective on Emerging Therapies to Achieve Functional Cure of Chronic Hepatitis B. Curr Hepatology Rep 2024.
Gopalakrishna, H., Mironova, M., Dahari, H., Koh C., Heller T. Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies. Curr Hepatology Rep 2024;23(1):32-44.
Vittal A, Niewisch MR, Bhala S, Kudaravalli P, Rahman F, Hercun J, Kleiner DE, Savage SA, Koh C, Heller T, Giri N. Progression of liver disease and portal hypertension in dyskeratosis congenita and related telomere biology disorders. Hepatology. 2023 Dec 1;78(6):1777-1787.
Klein RJ, Viana Rodriguez GM, Rotman Y, Brown RJ. Divergent pathways of liver fat accumulation, oxidation, and secretion in lipodystrophy versus obesity-associated NAFLD. Liver Int. 2023 Dec;43(12):2692-2700
Abdul Majeed N, Zehnder B, Koh C, Heller T, Urban S. Hepatitis delta: Epidemiology to recent advances in therapeutic agent.Hepatology. 2023 Oct 1;78(4):1306-1321.
Majeed NA, Hitawala AA, Heller T, Koh C. Diagnosis of HDV: From virology to non-invasive markers of fibrosis. Liver Int. 2023 Aug;43 Suppl 1(Suppl 1):31-46.
Hsu CC, Gopalakrishna H, Mironova M, Lee MH, Chen CJ, Yang HI, Wiese M, Chang KM, Wright EC, Abijo T, Feld JJ, Kaplan DE. Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review. Clin Infect Dis. 2023 Aug 14;77(Suppl 3):S245-S256
Majeed NA, Alawad AS, Liem KS, Takyar V, Alter H, Feld JJ, Janssen HLA, Ghany MG.Low Rate of Hepatitis B Reactivation Among Patients with Chronic Hepatitis C During Direct Acting Antiviral Therapy. Dis Sci. 2023 Jul;68(7):3193-3198. doi: 10.1007/s10620-023-07916-2
Shingina A, Chadha R, Lim N, Pillai A, Vodkin I, Montenovo M, Heller T, Yardeni D, Ganger D. Combined heart-liver transplantation practices survey in North America: Evaluation and organ listing practices. Liver Transpl. 2023 Jun 1;29(6):591-597
Vittal A, Abdul Majeed N, Garabedian E, Marko J, Kleiner DE, Sokolic R, Candotti F, Malech H, Heller T, Koh C. Severe combined immunodeficiency: improved survival leading to detection of underlying liver disease. BMC Gastroenterol. 2023 May 19;23(1):166.
Mironova M, Koh C, Heller T. Noninvasive measures of portal hypertension. Clin Liver Dis (Hoboken). 2023 Mar 20;22(2):58-61.
Yardeni D, Chang KM, Ghany MG. Current Best Practice in Hepatitis B Management and Understanding Long-term Prospets for Cure. Gastroenterology. 2023 Jan;164(1):42-60.e6.
Hitawala AA, Redmond C, Cowen EW, Kleiner DE, Hasni S, Heller T. Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report. J Investig Med High Impact Case Rep. 2023 Jan-Dec;11:23247096231171251. doi: 10.1177/23247096231171251. PMID: 37132021
Yang AH, Yardeni D, Hercun J, Kleiner DE, Ling A, Marko J, Heller T, Koh C. Shear wave elastography: How well does it perform in chronic hepatitis D virus infection? J Viral Hepat. 2022 Dec;29(12):1127-1133.
Hercun J, Noureddin M, Noureddin N, Eccleston J, Woolridge D, Liang TJ, Tana M, Kleiner DE, Rodriguez GV, Koh C, Hoofnagle JH, Heller T. Longitudinal Assessment of Bile Duct Loss in Primary Biliary Cholangitis. Am J Gastroenterol. 2022 Dec 1;117(12):2075-2078
Yardeni D, Hercun J, Rodriguez GV, Fontana JR, Kleiner DE, Koh C, Heller T.Reversal of Clinically Significant Portal Hypertension After Immunosuppressive Treatment in a Patient With Sarcoidosis. ACG Case Rep J. 2022 Oct 12;9(10):e00874.
Abdul Majeed N, Kleiner DE, Uzel G, Koh C, Heller T. Angiosarcoma in Long-Standing Nodular Regenerative Hyperplasia. ACG Case Rep J. 2022 Oct 18;9(10):e00863
Vittal A, Alao H, Hercun J, Sharma B, Khan A, Sharma D, Lee W, Kapuria D, Hsieh M, Tisdale J, Fitzhugh C, Kleiner D, Levy E, Chang R, Conrey A, Rivera E, Huang A, Yakov GB, Kato GJ, Gladwin MT, Thein SL, Koh C, Heller T. Safety of liver biopsy in patients with sickle cell related liver disease: A single-center experience. Am J Hematol. 2022 Jul;97(7):E257-E260
Yardeni D, Ghany MG. Review article: hepatitis B-current and emerging therapies. Aliment Pharmacol Ther. 2022 Apr;55(7):805-819.
Yardeni D, Heller T, Koh C. J Viral Hepat. 2022 Apr;29(4):240-251. Chronic hepatitis D-What is changing?
Vittal A, Sharma D, Hu A, Majeed NA, Terry N, Auh S, Ghany MG. Systematic review with meta-analysis: the impact of functional cure on clinical outcomes in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2022 Jan;55(1):8-25.
Da BL, Rahman F, Lai WC, Kleiner DE, Heller T, Koh C. Risk Factors for Delta Hepatitis in a North American Cohort: Who Should Be Screened?Am J Gastroenterol. 2021 Jan 1;116(1):206-209
Vittal A, Shapses M, Sharma B, Sharma D, Sun Q, Sampson M, Lee W, Ben Yakov G, Rotman Y. Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease. Hepatol Commun. 2020 Dec 29;5(4):589-597
Ben Yakov G, Sharma D, Cho MH, Shah NN, Hickstein D, Urban A, Darnell D, Kapuria D, Marko J, Kleiner DE, Hadigan CM, Danielson J, Ham H, Vittal A, Su HC, Freeman AF, Heller T. Cryptosporidium infection in dedicator of cytokinesis 8 (DOCK 8) deficiency. J Allergy Clin Immunol Pract. 2020 Nov-Dec;8(10):3663-3666.
Abdul Majeed N, Font-Montgomery E, Lukose L, Bryant J, Veppumthara P, Choyke PL, Turkbey IB, Heller T, Gahl WA, Gunay-Aygun M. Prospective evaluation of kidney and liver disease in autosomal recessive polycystic kidney disease-congenital hepatic fibrosis. Mol Genet Metab. 2020 Sep-Oct;131(1-2):267-276.
Rubin JN, Gilman CAL, Gasmi B, Stern WR, Hernandez JM, Koh C. Hepatocellular Carcinoma Where You Least Expect It Am J Gastroenterol. 2020 Jul;115(7):1134-1136.
Da BL, Surana P, Kapuria D, Vittal A, Levy E, Kleiner DE, Koh C, Heller T. Portal Pressure in Noncirrhotic Portal Hypertension: To Measure or Not to Measure. Hepatology. 2019 Dec;70(6):2228-2230
Da BL, Surana P, Schueler SA, Jalaly NY, Kamal N, Taneja S, Vittal A, Gilman CL, Heller T, Koh C. Twitter As a Noninvasive Bio-Marker for Trends in Liver Disease. Hepatol Commun. 2019 Jul 13;3(9):1271-1280.
Recent Abstracts and Presentations
Maria Mironova, Harish Gopalakrishna, Nehna Abdul Majeed, Asif Hitawala, Shani Scott, David Kleiner, Cristopher Koh, Bernadette Redd, Theo Heller. Features of non-cirrhotic portal hypertension in a prospective evaluation of magnetic resonance imaging. Abstract #1613-2023 AASLD Annual Liver Meeting
Maria Mironova, Paul S Blank, Regina Umarova, Yaron Rotman. Postprandial plasma proteomics in non-alcoholic fatty liver disease. Abstract #2414-C-2023 AASLD Annual Liver Meeting
Maria Mironova, Harish Gopalakrishna, Nehna Abdul Majid, Asif Hitawala, Shani Scott, David Kleiner, Christopher Koh, Theo Heller. Prospective evaluation of patients with non-cirrhotic portal hypertension: a single center study. Abstract #3160-A-2023 AASLD Annual Liver Meeting
Maria Mironova, Paul S Blank, Regina Umarova, Mary Walter, Yaron Rotman. Postprandial plasma proteomics in metabolic dysfunction-associated steatotic liver disease. NASH TAG (Therapeutic Agents for Non-Alcoholic Steatohepatitis and Liver Fibrosis) 2024
Harish Gopalakrishna, Ruth Pfeiffer, Sabrina C Ramelli, Sabrina Chen, Ludmila Prokunina-Olsson, Stephen M Hewitt, David E. Kleiner, Marc G. Ghany, Thomas R. O'Brien. Role of IFNL4 genotype in Hepatic Inflammation among Black Individuals with Chronic Hepatitis C. Abstract #2613-A- 2023 AASLD Annual Liver Meeting
Harish Gopalakrishna, Gayatri Nair, Roham Salman Roghani, Natarajan Ravendhran, Yaron Rotman. Optimizing Surveillance Frequency Using Transient Elastography in Low-risk Nonalcoholic Fatty Liver Disease. Abstract # 2087-A-2023 AASLD Annual Liver Meeting
Harish Gopalakrishna, Maria Mironova, My-Le Nguyen, Gracia Viana, Gayatri Nair, David E Kleiner, Christopher Koh, Vandana Sachdev and Theo Heller.Cardiopulmonary Dysfunction, and its Correlation with Disease Severity in Noncirrhotic Portal Hypertension. Abstract #1612-A- 2023 AASLD Annual Liver Meeting
Harish Gopalakrishna, Maria Mironova, Nehna Abdul Majeed, Asif Ali Hitawala, Shani Scott, Jaha Norman-Wheeler, David E Kleiner, Christopher Koh, Theo Heller. A Noninvasive model to predict Clinically significant portal hypertension in Noncirrhotic portal hypertension. Abstract # 3132-A-2023 AASLD Annual Liver Meeting